Published in J Diabetes Complications on September 12, 2012
Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus. Nephrol Dial Transplant (2015) 1.49
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci Transl Med (2015) 1.03
Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes. Exp Ther Med (2013) 0.89
Therapeutic targets for treating fibrotic kidney diseases. Transl Res (2014) 0.88
New urinary biomarkers for diabetic kidney disease. Biomark Res (2013) 0.82
Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial. Clin J Am Soc Nephrol (2016) 0.80
Assessment of urinary osteopontin in association with podocyte for early predication of nephropathy in diabetic patients. Dis Markers (2014) 0.80
The next generation of therapeutics for chronic kidney disease. Nat Rev Drug Discov (2016) 0.79
Urinary biomarkers for early diabetic nephropathy: beyond albuminuria. Pediatr Nephrol (2014) 0.79
Urinary concentration of monocyte chemoattractant protein-1 in idiopathic glomerulonephritis: a long-term follow-up study. PLoS One (2014) 0.78
Urinary Markers of Tubular Injury in Early Diabetic Nephropathy. Int J Nephrol (2016) 0.78
Urinary Kininogen-1 and Retinol binding protein-4 respond to Acute Kidney Injury: predictors of patient prognosis? Sci Rep (2016) 0.76
Developing Treatments for Chronic Kidney Disease in the 21st Century. Semin Nephrol (2016) 0.75
Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis. PLoS One (2017) 0.75
Evaluation of Ischemia-Modified Albumin, Malondialdehyde, and Advanced Oxidative Protein Products as Markers of Vascular Injury in Diabetic Nephropathy. Biomark Insights (2016) 0.75
Are Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta Analysis. PLoS One (2016) 0.75
Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy. BMC Nephrol (2015) 0.75
Urinary Retinol-Binding Protein: Relationship to Renal Function and Cardiovascular Risk Factors in Chronic Kidney Disease. PLoS One (2016) 0.75
Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review. BMC Nephrol (2017) 0.75
Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus. PLoS One (2017) 0.75
GATE: a simulation toolkit for PET and SPECT. Phys Med Biol (2004) 7.88
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest (1986) 2.96
Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension (1992) 1.95
Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A (1985) 1.85
ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial. Clin Nephrol (2011) 1.58
Detection and partial characterization of circulating immune complexes with solid-phase anti-C3. J Immunol (1980) 1.54
Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am J Med (1986) 1.50
A comparative immunologic analysis of several murine strains with autoimmune manifestations. Clin Immunol Immunopathol (1980) 1.23
Predictive value of urinary retinol binding protein for graft dysfunction after kidney transplantation. Transplant Proc (2003) 1.15
Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney Int (2001) 1.13
Comparative study of IgA nephropathy with and without crescents. Braz J Med Biol Res (2004) 1.06
Effects of Hg(II) exposure on MAPK phosphorylation and antioxidant system in D. melanogaster. Environ Toxicol (2012) 1.06
Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy. J Am Soc Nephrol (1995) 1.05
Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). Am J Transplant (2013) 1.03
Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study. Am J Transplant (2013) 1.00
Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int (1998) 0.98
Cytokine profiles in women with different subtypes of major depressive disorder. J Psychiatr Res (2005) 0.98
Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade. Hypertension (1996) 0.96
Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney. J Am Soc Nephrol (2000) 0.96
Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats. Am J Physiol (1994) 0.94
Presence of circulation immune complexes in Reiter's syndrome and ankylosing spondylitis. Clin Immunol Immunopathol (1981) 0.93
The renal hemodynamic response to amino acid infusion in the rat. Trans Assoc Am Physicians (1983) 0.92
Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug. N Engl J Med (2000) 0.92
Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Hypertension (2001) 0.91
Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Res Cardiol (1996) 0.89
Worse renal outcome of lupus nephritis in male patients: a case-control study. Lupus (2011) 0.87
Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. Am J Physiol (1994) 0.87
Lupus nephritis is more severe in children and adolescents than in older adults. Lupus (2012) 0.86
Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes. Nephron (1996) 0.85
Renal abnormalities in leprosy. Nephron (1993) 0.84
Osteomalacia secondary to renal tubular acidosis in a patient with primary Sjögren's syndrome. Clin Exp Rheumatol (1992) 0.83
Nifedipine prevents renal injury in rats with chronic nitric oxide inhibition. Hypertension (1995) 0.83
Absence of focal glomerulosclerosis in aging analbuminemic rats. Am J Physiol (1992) 0.82
Nitroflurbiprofen, a new nonsteroidal anti-inflammatory, ameliorates structural injury in the remnant kidney. Am J Physiol (1998) 0.82
Mechanisms of albuminuria in the chronic nitric oxide inhibition model. Am J Physiol Renal Physiol (2000) 0.82
A locus for adolescent and adult onset familial focal segmental glomerulosclerosis on chromosome 1q25-31. J Am Soc Nephrol (2000) 0.82
Vestibular and cochlear efferent neurons in the monkey identified by immunocytochemical methods. Brain Res (1987) 0.82
Prediction of steroid responsiveness in the idiopathic nephrotic syndrome using urinary retinol-binding protein and beta-2-microglobulin. Ann Intern Med (1992) 0.82
Effect of arginine analogues on rat hind paw oedema and mast cell activation in vitro. Eur J Pharmacol (1994) 0.81
How cells die counts. Am J Kidney Dis (2000) 0.81
Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis. Eur J Pharmacol (1995) 0.81
Effect of Ca2+ channel blockers on arterial hypertension and heart ischaemic lesions induced by chronic blockade of nitric oxide in the rat. Eur J Pharmacol (1999) 0.81
Evidences for a role of glutathione peroxidase 4 (GPx4) in methylmercury induced neurotoxicity in vivo. Toxicology (2012) 0.81
Glomerular hematuria in diabetics. Clin Nephrol (1988) 0.80
Assessment of lupus nephritis activity using urinary retinol-binding protein. Nephrol Dial Transplant (1994) 0.80
Serum levels of prostate-specific antigen in normal boys throughout puberty. J Clin Endocrinol Metab (1994) 0.80
Nephrology, dialysis and transplantation in Brazil. Nephrol Dial Transplant (1997) 0.79
Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury. J Hypertens Suppl (1986) 0.79
Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease. Nephron Physiol (2005) 0.79
Effect of chronic nitric oxide synthesis inhibition on the inflammatory responses induced by carrageenin in rats. Eur J Pharmacol (1995) 0.79
Antimicrobial resistance of strains of the Bacteroides fragilis group isolated from the intestinal tract of children and adults in Brazil. Int J Antimicrob Agents (2001) 0.79
The renal and hepatic distribution of Bence Jones proteins depends on glycosylation: a scintigraphic study in rats. Braz J Med Biol Res (1997) 0.79
Egg yolk as a source of antibodies for human parathyroid hormone (hPTH) radioimmunoassay. J Immunoassay (1984) 0.78
Detection of IgG-rheumatoid factor in sera of patients with acute poststreptococcal glomerulonephritis and its relationship with circulating immunecomplexes. Clin Nephrol (1986) 0.78
Measurement of salivary, urinary and fecal secretory IgA levels in children with partial or total IgA deficiency. J Investig Allergol Clin Immunol (1995) 0.78
Urinary retinol binding protein is a good marker of progressive cyclosporine nephrotoxicity after heart transplant. Transplant Proc (2001) 0.78
Frequent abnormalities of renal function in patients with rheumatoid arthritis. Nephron (1991) 0.78
Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation. Am J Physiol Renal Physiol (2011) 0.78
Nephrotic syndrome associated with hepatointestinal schistosomiasis. Rev Inst Med Trop Sao Paulo (1994) 0.77
The clinical diagnosis of hypertensive nephrosclerosis--how reliable is it? Nephrol Dial Transplant (1999) 0.77
Progressive hypervolemia despite hypoproteinemia and massive edema formation in rats with nephrotoxic serum nephritis. Ren Physiol Biochem (1990) 0.77
Non-specific inhibitors of nitric oxide synthase cause myocardial necrosis in the rat. Clin Exp Pharmacol Physiol (1997) 0.77
Urinary retinol-binding protein as a prognostic marker in the treatment of nephrotic syndrome. Nephron (2000) 0.77
Pathogenesis of glomerular sclerosis in subtotally nephrectomized analbuminemic rats. Am J Physiol (1991) 0.77
Immunoassays of secretory IgA and secretory component. Braz J Med Biol Res (1990) 0.77
Inherited C3 deficiency of the complement system. Braz J Med Biol Res (1988) 0.77
Is the lobster cockroach Nauphoeta cinerea a valuable model for evaluating mercury induced oxidative stress? Chemosphere (2013) 0.77
Collapsing glomerulopathy associated with proliferative lupus nephritis: reversible acute kidney injury. Lupus (2010) 0.76
Decreased in vitro osteoblast proliferation and low turnover bone disease in nonuremic proteinuric patients. Kidney Int (2007) 0.76
Do ETA receptors participate in the hemodynamic and renal effects of chronic nitric oxide blockade? J Cardiovasc Pharmacol (1995) 0.76
Determination of renal function in long-term heart transplant patients by measurement of urinary retinol-binding protein levels. Braz J Med Biol Res (2006) 0.76
Corrosion behaviour of AISI 316L stainless-steel alloys in diabetic serum. Clin Mater (1993) 0.76
The biology of immune complexes and their possible role in pregnancy. Am J Reprod Immunol (1981) 0.76
High-titer antichromatin antibody is associated with proliferative class IV of lupus nephritis. Clin Rheumatol (2008) 0.75
Exposure to hydrocarbons and rapidly progressive glomerulonephritis. Braz J Med Biol Res (1990) 0.75
Lupus nephritis and HCV infection. Nephrol Dial Transplant (1997) 0.75
Immunocytochemical features of the vestibular nuclei in the monkey and cat. J Hirnforsch (1990) 0.75
Early detection of heart transplant patients with increased risk of ciclosporin nephrotoxicity. Lancet (2001) 0.75
Increased production of beta-2 microglobulin in stable renal transplant patients. Transplantation (1995) 0.75
Physiologic role of ETA receptors in the regulation of renal hemodynamics in normal and salt-depleted rats. J Cardiovasc Pharmacol (1995) 0.75
Characterisation of functional endothelin receptors in the canine isolated perfused spleen. Eur J Pharmacol (1995) 0.75
Heterogeneity of glomerular perfusion and filtration induced by epinephrine and norepinephrine. Braz J Med Biol Res (1997) 0.75
Lowering of arterial blood pressure limits glomerular sclerosis in rats with renal ablation and in experimental diabetes. Kidney Int Suppl (1987) 0.75
Role of endothelin ETA and ETB receptors in the arterial vasculature of the isolated canine liver. J Cardiovasc Pharmacol (1995) 0.75
Assessment of glomerular filtration rate utilizing subcutaneously injected 51Cr-EDTA. Braz J Med Biol Res (1994) 0.75
Quantitation of salivary, urinary and faecal sIgA in children living in different conditions of antigenic exposure. J Trop Pediatr (1993) 0.75
Dissimilarity between prostaglandin E1 and nitric oxide donors as potentiators of plasma exudation in the rabbit skin in vivo. Prostaglandins Leukot Essent Fatty Acids (1995) 0.75
[Pharmacokinetics of cyclosporine and its metabolites in patients undergoing kidney transplantation]. Rev Assoc Med Bras (1995) 0.75
Salivary secretory IgA reference values in Brazilian healthy children. J Trop Pediatr (1996) 0.75
Specific and nonspecific aspects of humoral immune response in leprosy. Braz J Med Biol Res (1994) 0.75
[Optimization of the use of cyclosporin in renal transplantation]. Rev Assoc Med Bras (1993) 0.75
Sodium handling and renal hemodynamics in euvolemic and volume-expanded nephrotic rats. Braz J Med Biol Res (1986) 0.75
Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy. Diabetes (1992) 0.75
Metabolic study in dysmorphic hematuria. Nephron (1992) 0.75
Prevalence of hepatitis C virus antibodies in primary glomerulonephritis in Brazil. Am J Nephrol (1998) 0.75
[Serum beta 2 microglobulin (beta 2M) following renal transplantation]. Rev Assoc Med Bras (1995) 0.75
Quantification of salivary, urinary and fecal secretory IgA, as well as in saliva titers and avidities of IgA antibodies in children living at different levels of antigenic exposure and undernutrition. Adv Exp Med Biol (1995) 0.75
Urinary abnormalities in chronic hepatitis C--a follow-up study. Nephron (1998) 0.75